Sanofi reported EUR60M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Canopy Growth CAD 3.86M 1.89M Mar/2026
Corcept Therapeutics USD 5.42M 399K Dec/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 22M 4M Mar/2026
J&J USD 2.14 237M Mar/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck USD 69M 27M Dec/2025
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 33M 81M Dec/2025
Sanofi EUR 60M 54M Mar/2026
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
Zoetis USD 25M 1000K Dec/2025